 Oral intravesical bacillus Calmette-Guerin immunoprophylaxis bladder carcinoma total patients superficial transitional cell carcinoma underwent transurethral resection bladder tumor patients stage pTa transitional cell carcinoma carcinoma situ concurrent malignancies patients treatment groups control group transurethral resection study oral bacillus Calmette-Guerin BCG group transurethral resection bladder tumor BCG Moreau intravesical BCG group transurethral resection bladder tumor BCG patients control group tumor recurrence mean followup months patients oral BCG group recurrence mean followup months patients intravesical group recurrence mean followup incidence complications intravesical oral BCG group results intravesical BCG effective immunotherapy oral BCG patients intravesical BCG administration